539 related articles for article (PubMed ID: 19646078)
1. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
Westerlund T; Marklund B
J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical care in community pharmacies: practice and research in Sweden.
Westerlund LT; Björk HT
Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
[TBL] [Abstract][Full Text] [Related]
3. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
4. [Pharmaceutical care for drug-related problems in inpatients].
Gorgas Torner MQ; Odena Estradé E; Pastor Solernou F
Farm Hosp; 2003; 27(5):280-9. PubMed ID: 14576917
[TBL] [Abstract][Full Text] [Related]
5. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
[TBL] [Abstract][Full Text] [Related]
6. The health care cost of drug-related morbidity and mortality in nursing facilities.
Bootman JL; Harrison DL; Cox E
Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
[TBL] [Abstract][Full Text] [Related]
7. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
Smith DH; Fassett WE; Christensen DB
J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
[TBL] [Abstract][Full Text] [Related]
8. Documenting concurrent clinical pharmacy interventions.
Haslett TM; Kay BG; Weissfellner H
Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.
Grabe DW; Low CL; Bailie GR; Eisele G
Clin Nephrol; 1997 Feb; 47(2):117-21. PubMed ID: 9049460
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics of adverse drug reactions.
Lundkvist J; Jönsson B
Fundam Clin Pharmacol; 2004 Jun; 18(3):275-80. PubMed ID: 15147278
[TBL] [Abstract][Full Text] [Related]
11. Development, implementation, and evaluation of a community pharmacy-based asthma care model.
Saini B; Krass I; Armour C
Ann Pharmacother; 2004 Nov; 38(11):1954-60. PubMed ID: 15479780
[TBL] [Abstract][Full Text] [Related]
12. A pharmacist model of perceived responsibility for drug therapy outcomes.
Planas LG; Kimberlin CL; Segal R; Brushwood DB; Hepler CD; Schlenker BR
Soc Sci Med; 2005 May; 60(10):2393-403. PubMed ID: 15748686
[TBL] [Abstract][Full Text] [Related]
13. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).
Viktil KK; Blix HS; Moger TA; Reikvam A
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):667-74. PubMed ID: 16598835
[TBL] [Abstract][Full Text] [Related]
14. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia.
Paulós CP; Nygren CE; Celedón C; Cárcamo CA
Ann Pharmacother; 2005 May; 39(5):939-43. PubMed ID: 15827075
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical value of pharmacists' modifications of prescription errors.
Buurma H; De Smet PA; Leufkens HG; Egberts AC
Br J Clin Pharmacol; 2004 Nov; 58(5):503-11. PubMed ID: 15521898
[TBL] [Abstract][Full Text] [Related]
16. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic evaluation of pharmacists' contribution to patient care on a multi-disciplinary liver transplant team.
Ah YM; Lee JY; Moon MR; Cho YS; Kim HS; Yi NJ; Lee KW; Suh KS
Int J Clin Pharmacol Ther; 2016 Feb; 54(2):102-9. PubMed ID: 26709599
[TBL] [Abstract][Full Text] [Related]
18. Drug-related problems on hospital admission: relationship to medication information transfer.
Ong SW; Fernandes OA; Cesta A; Bajcar JM
Ann Pharmacother; 2006 Mar; 40(3):408-13. PubMed ID: 16492794
[TBL] [Abstract][Full Text] [Related]
19. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
[TBL] [Abstract][Full Text] [Related]
20. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
Miyagawa CI; Rivera JO
Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
